116 related articles for article (PubMed ID: 2242526)
1. Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension.
Palevsky HI; Long W; Crow J; Fishman AP
Circulation; 1990 Dec; 82(6):2018-26. PubMed ID: 2242526
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.
Rubin LJ; Groves BM; Reeves JT; Frosolono M; Handel F; Cato AE
Circulation; 1982 Aug; 66(2):334-8. PubMed ID: 7046988
[TBL] [Abstract][Full Text] [Related]
3. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
Sitbon O; Brenot F; Denjean A; Bergeron A; Parent F; Azarian R; Herve P; Raffestin B; Simonneau G
Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):384-9. PubMed ID: 7842196
[TBL] [Abstract][Full Text] [Related]
4. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension.
Jones K; Higenbottam T; Wallwork J
Chest; 1989 Oct; 96(4):784-9. PubMed ID: 2507232
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
7. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
McLaughlin VV; Genthner DE; Panella MM; Rich S
N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
[TBL] [Abstract][Full Text] [Related]
8. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
9. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension.
Raffy O; Azarian R; Brenot F; Parent F; Sitbon O; Petitpretz P; Hervé P; Duroux P; Dinh-Xuan AT; Simonneau G
Circulation; 1996 Feb; 93(3):484-8. PubMed ID: 8565165
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
12. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
[TBL] [Abstract][Full Text] [Related]
14. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension.
Castelain V; Chemla D; Humbert M; Sitbon O; Simonneau G; Lecarpentier Y; Hervé P
Am J Respir Crit Care Med; 2002 Feb; 165(3):338-40. PubMed ID: 11818317
[TBL] [Abstract][Full Text] [Related]
16. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
[TBL] [Abstract][Full Text] [Related]
17. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
[TBL] [Abstract][Full Text] [Related]
18. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.
Barst RJ; Rubin LJ; McGoon MD; Caldwell EJ; Long WA; Levy PS
Ann Intern Med; 1994 Sep; 121(6):409-15. PubMed ID: 8053614
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension: predictive ability and consequences on haemodynamics and gas exchange.
Jolliet P; Bulpa P; Thorens JB; Ritz M; Chevrolet JC
Thorax; 1997 Apr; 52(4):369-72. PubMed ID: 9196521
[TBL] [Abstract][Full Text] [Related]
20. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.
Rubin LJ; Mendoza J; Hood M; McGoon M; Barst R; Williams WB; Diehl JH; Crow J; Long W
Ann Intern Med; 1990 Apr; 112(7):485-91. PubMed ID: 2107780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
